Willingness to use a supervised injection facility among young adults who use prescription opioids non-medically: a cross-sectional study

DSpace/Manakin Repository

Willingness to use a supervised injection facility among young adults who use prescription opioids non-medically: a cross-sectional study

Citable link to this page

 

 
Title: Willingness to use a supervised injection facility among young adults who use prescription opioids non-medically: a cross-sectional study
Author: Bouvier, Benjamin A.; Elston, Beth; Hadland, Scott E.; Green, Traci C.; Marshall, Brandon D. L.

Note: Order does not necessarily reflect citation order of authors.

Citation: Bouvier, Benjamin A., Beth Elston, Scott E. Hadland, Traci C. Green, and Brandon D. L. Marshall. 2017. “Willingness to use a supervised injection facility among young adults who use prescription opioids non-medically: a cross-sectional study.” Harm Reduction Journal 14 (1): 13. doi:10.1186/s12954-017-0139-0. http://dx.doi.org/10.1186/s12954-017-0139-0.
Full Text & Related Files:
Abstract: Background: Supervised injection facilities (SIFs) are legally sanctioned environments for people to inject drugs under medical supervision. SIFs currently operate in ten countries, but to date, no SIF has been opened in the USA. In light of increasing overdose mortality in the USA, this study evaluated willingness to use a SIF among youth who report non-medical prescription opioid (NMPO) use. Methods: Between January 2015 and February 2016, youth with recent NMPO use were recruited to participate in the Rhode Island Young Adult Prescription Drug Study (RAPiDS). We explored factors associated with willingness to use a SIF among participants who had injected drugs or were at risk of initiating injection drug use (defined as having a sex partner who injects drugs or having a close friend who injects). Results: Among 54 eligible participants, the median age was 26 (IQR = 24–28), 70.4% were male, and 74.1% were white. Among all participants, when asked if they would use a SIF, 63.0% answered “Yes”, 31.5% answered “No”, and 5.6% were unsure. Among the 31 participants reporting injection drug use in the last six months, 27 (87.1%) reported willingness to use a SIF; 15 of the 19 (78.9%) who injected less than daily reported willingness, while all 12 (100.0%) of the participants who injected daily reported willingness. Compared to participants who were unwilling or were unsure, participants willing to use a SIF were also more likely to have been homeless in the last six months, have accidentally overdosed, have used heroin, have used fentanyl non-medically, and typically use prescription opioids alone. Conclusions: Among young adults who use prescription opioids non-medically and inject drugs or are at risk of initiating injection drug use, more than six in ten reported willingness to use a SIF. Established risk factors for overdose, including homelessness, history of overdose, daily injection drug use, heroin use, and fentanyl misuse, were associated with higher SIF acceptability, indicating that young people at the highest risk of overdose might ultimately be the same individuals to use the facility. Supervised injection facilities merit consideration to reduce overdose mortality in the USA. Electronic supplementary material The online version of this article (doi:10.1186/s12954-017-0139-0) contains supplementary material, which is available to authorized users.
Published Version: doi:10.1186/s12954-017-0139-0
Other Sources: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5319157/pdf/
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:31731807
Downloads of this work:

Show full Dublin Core record

This item appears in the following Collection(s)

 
 

Search DASH


Advanced Search
 
 

Submitters